Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
51,951,129
-
Shares change
-
+684,161
-
Total reported value, excl. options
-
$1,828,229,880
-
Value change
-
+$28,751,282
-
Put/Call ratio
-
79%
-
Number of buys
-
117
-
Number of sells
-
-103
-
Price
-
$35.19
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q2 2023
253 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share as of Q2 2023.
Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51,951,129 shares
of 57,417,494 outstanding shares and own 90% of the company stock.
Largest 10 shareholders include Valor Management LLC (11,218,033 shares), BlackRock Inc. (5,750,478 shares), FMR LLC (5,470,247 shares), VANGUARD GROUP INC (3,595,857 shares), Vivo Capital, LLC (2,606,247 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,200,000 shares), STATE STREET CORP (1,140,934 shares), venBio Partners LLC (1,035,396 shares), MACQUARIE GROUP LTD (901,528 shares), and PERCEPTIVE ADVISORS LLC (891,370 shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.